Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Join PfizerLink — a clinical research registry

      Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      9 trials found for Lymphoma

      All(9)
      Recruiting(7)
      Not yet recruiting(2)
      Recruiting
      NCT03460977
      PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

      Castration Resistant Prostate Cancer (CRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)

      Male or Female
      18+ years
      138study location(s)
      Recruiting
      NCT06120504
      A Safety Study of SGN-35T in Adults With Advanced Cancers

      Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin

      Male or Female
      18+ years
      2study location(s)
      Recruiting
      NCT05896774
      A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

      Non-Hodgkin Lymphoma, Multiple Myeloma

      Male or Female
      18+ years
      6study location(s)
      Recruiting
      NCT05626322
      Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

      Diffuse Large B-Cell Lymphoma

      Male or Female
      18+ years
      44study location(s)
      Recruiting
      NCT05896163
      A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

      Diffuse Large B-Cell Lymphoma

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT05160922
      Crizotinib Continuation Clinical Study

      NSCLC, ALCL, IMT

      Male or Female
      1 - 99 years
      14study location(s)
      Recruiting
      NCT05144997
      Lorlatinib Continuation Study

      Non-Small-Cell Lung Cancer, NSCLC

      Male or Female
      18+ years
      18study location(s)
      Sep 01, 2024 - Planned start date (Not yet recruiting)
      NCT06333899
      Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

      High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, Infant Type Hemispheric Glioma, Glioblastoma, Glioblastoma Multiforme, WHO Grade III Glioma, WHO Grade IV Glioma, Diffuse Midline Glioma, H3K27-altered

      Male or Female
      1 - 21 years
      17study location(s)
      May 31, 2024 - Planned start date (Not yet recruiting)
      NCT06254495
      A Safety Study of SGN-35C in Adults With Advanced Cancers

      Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

      Male or Female
      18+ years
      1study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(9)
      Recruiting(7)
      Not yet recruiting(2)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.